Cheryl V. Reicin

Cheryl V. Reicin

New York: 212.880.6067
Toronto: 416.865.7373
Fax 212.682.0200


JD, 1984
Harvard Law School
BA (summa cum laude), 1980
Barnard College, Columbia University

Bar Admissions

Massachusetts, 1989 New York, 1985 Foreign Legal Consultant, Ontario, 2005


“Great to work with, is creative, is whip-smart, so you can trust that she will reach the right conclusions.” - LMG Life Sciences

Cheryl is the practice leader of Torys’ Life Science Group, a cross-border group in both Canada and New York. Cheryl represents the whole spectrum of biotech, medical device and health technology companies, from start-ups to large public companies, as well as venture capitalists, investment banks and academic medical centers. She advises companies, in joint ventures and licensing transactions, financing and mergers and acquisitions throughout the world.

Cheryl assists companies in formulating domestic and international growth strategies and in sourcing capital. She advises on venture and later-stage financings, IPOs, mergers and acquisitions, licensing transactions and joint ventures or alliances with strategic partners. She also coordinates domestic and international structuring, intellectual property planning and regulatory strategy.

Cheryl has been a three time awardee of WXN’s Canada’s Top 100 Most Powerful Women.

Prior to joining Torys, Cheryl led the 85 attorney life science group of a U.S. law firm.

Representative Work

Load More


Chambers & Partners’ Chambers Canada—Leading lawyer in life sciences (2017-2019); Recognized practitioner in cannabis law (2019)

Best Lawyers in Canada—2014 Biotechnology Law Lawyer of the Year; Leading lawyer in biotechnology law (2010-2019)

Law Business Research’s International Who’s Who of Life Sciences Lawyers—Leading lawyer in transactional law (2010-2014, 2019)

Law Business Research’s Who’s Who Legal Canada and New York—Leading lawyer in life sciences (2010-2018)

Lexpert/Thomson Reuters Canada’s Canadian Legal Lexpert Directory—Repeatedly recommended practitioner in biotechnology; technology transactions (2008-2019)

Women's Executive Network (WXN) Canada's Most Powerful Women: Top 100 Award (2014, 2016, 2017)

LMG Life Sciences— Finance & Transactional Lawyer of the Year (2013); LMG Life Sciences Star (2014-2017); Finance & Transactional Firm of the Year (2018); Canadian Deal of the Year (2018)

Expert Guides: Best of the Best—Leading lawyer in Life Sciences (2019)

Expert Guides: Women in Business Law Guide—Leading practitioner in life sciences (2014-2017)

IAM Patent 1000: The World's Leading IP Transactions —Leading lawyer globally (2012-2016)

Women of Influence, 2013 and 2014—Canada’s Top 25 Women of Influence (No. 1 in Professional Services category)

Law Business Research’s Who’s Who Legal: International Who’s Who of Business Lawyers—Leading lawyer in life sciences (2010-2014)

IAM Licensing 250: The World’s Leading Patent and Technology Licensing Lawyers—Leading lawyer globally (2010-2012)

Practical Law Company’s Which Lawyer? Yearbook 2010-2012—Highly recommended lawyer in life sciences: corporate and commercial

Lexpert/American Lawyer Media’s Guide to the Leading 500 Lawyers in Canada 2006—Leading practitioner in serving the corporate midmarket


W*I*T*H Canadian Launch


Professional Involvement

Before joining Torys, Cheryl was a partner of a large international law firm, where she chaired an 85-attorney life sciences group.


Current Directorships

The Hospital for Sick Children Foundation (Director)
The Hospital for Sick Children (Trustee)
The Hospital for Sick Children Commercialization Advisory Board
The Hospital for Sick Children Finance and Audit Committee
The Hospital for Sick Children Research Institute Review Advisory Committee (Member)
Institute for the Study of Aging (Business Advisory Board)
Genesis, incubator for social entrepreneurship (Chair and Founder)
W*I*T*H (women Innovating Together in Health)
TO Health! (Steering Committee)

Past Directorships

PREVENT (Pan-Provincial Vaccine Enterprise Inc.) (Director)
Health Technology Exchange (HTX) (Advisory Board)
Health Technologies Fund (External Review Panel (ERP)
Alzheimer’s Drug Discovery Foundation (Director)
The Centre for Israel and Jewish Affairs (Director)
OCE/CQDM Life Sciences R&D Challenge (Review Panel)
Hadassit, the technology transfer subsidiary of Hadassah Medical Center, Jerusalem (Advisory Board)
Journal of BioLaw and Business (Editorial Advisory Board)
Entrepreneurship Institute (Director)
Ontario Genomics Institute (Director)
Artists 4 Israel (Director)
Baycrest Centre for Geriatric Care (Research Advisory Committee)
Jerusalem College of Technology (Director)
BIO International Committee